A Swiss Innovation in the battle against Gram-Positive Gram-Negative Bacteria
The battle against wound bacteria
The rapid therapeutic effect of PATHELEN® HYBRID THERAPY against bacteria is achieved by various simultaneous complex mechanisms of action.
- Prevention and elimination of biofilm
- Sorption of pus and toxins (including large amounts of problematic lipopolysaccharides)
- Formation of a physiological wound environment with granular tissue
Quickly after the first application, there is a significant improvement in the general condition in the patient.PATHELEN® HYBRID THERAPY not only accelerates wound healing and succeeds to heal even “hard-to-heal” wounds by keeping wound bacteria under control, but also significantly improves the quality of life for our patients.
When bacteria is not under control, wounds won’t heal. Pathelen accelerates the wound healing process by keeping bacteria under control.
A fighting chance against Multi resistant Bacteria like MRSA and Pseudomonas
The main requirements for wound healing are a sufficient blood circulation at the wound and reducing and controlling its wound bacteria. For any bacteria, wounds are a preferred playground. In the right environment bacteria can double in quantity every 20-30 minutes. As long as proliferation of bacteria is not under control, wounds won’t heal.
Multi-resistant germs keep medicine in suspense worldwide, and common forms are MRSA bacteria. However, Klebsiella and Escherichia coli (EHEC), which increasingly form Extended Spectrum beta-lactamases, i.e. enzymes that can inactivate the beta-lactam antibiotics, are much more aggressive, preferred entry gates are wounds.
CLINICAL CASE STUDIES
The PATHELEN® HYBRID wound care therapy has been tested on patients in various hospitals around the world.
A wide variety of wound infections have been treated successfully with chronic wounds, including MRSA patients, having healed completely.